Daxxify Gaining Ground as Long-Duration Alternative to Botox
Aesthetic Surgery Journal · Revance Therapeutics
FDA-approved prabotulinumtoxinA (Daxxify) is showing 6-month duration in clinical practice — nearly double traditional Botox. Early adopter spas report patients willing to pay a 30–40% premium for the extended result. Market share is growing rapidly in the South and Southeast.
Affects: Neurotoxin services
High Relevance ↗
Treatment
🔥 Hot
5 days ago
Exosome Therapy Emerges as the Next Premium Skin Regeneration Protocol
Dermatology Times · ISAC Research
Cell-derived exosomes applied post-microneedling or laser are demonstrating measurable collagen density and elasticity improvements in clinical studies. Not yet FDA-cleared as standalone, but legal as an adjunct to cleared devices. Early-mover spas are commanding $400–$650 per session.
Affects: Skin rejuvenation, add-ons
High Relevance ↗
Industry
🔥 Hot
6 days ago
The GLP-1 Effect: Med Spas Seeing 40% Spike in Body Contouring After Ozempic Weight Loss
MedEsthetics · ASPS Survey Data 2025
Patients on semaglutide experiencing rapid weight loss are creating downstream demand for skin tightening, body contouring, and facial volume restoration. Spas integrating GLP-1 patient pathways report 18–25% revenue increases per patient. This is the single biggest structural shift in med spa demand in the past decade.
Affects: Body contouring, fillers, skin tightening
High Relevance ↗
Device
1 week ago
InMode Expands Morpheus8 Body Protocols — Full-Body RF Microneedling Now Viable
Aesthetic Buyers Guide · InMode Clinical Update
Updated handpiece configurations enable full-body Morpheus8 applications including abdomen, thighs, and arms. Spas with existing platforms can expand revenue per device with a training-only upgrade — no new equipment required. Average body treatment ticket: $1,200–$2,400 per session.
Affects: Body contouring
Medium Relevance ↗
Treatment
1 week ago
Profhilo Bioremodelling Enters US Market Through Select Distributors
Dermatology News · IBSA Pharma
Italy’s leading bioremodelling injectable — a high-concentration hyaluronic acid that stimulates collagen without adding volume — is now available through licensed US distributors. Early practices report it filling a distinct gap between HydraFacials and dermal fillers, priced at $600–$900 per treatment.
Affects: Skin boosters, injectable menu
Medium Relevance ↗
Device
10 days ago
AI Skin Analysis Cameras Reporting 34% Higher Package Conversion in Consultations
Aesthetic Practice Today · Canfield Scientific
Next-gen imaging systems like the Canfield VISIA and OBSERV 520x use AI to detect subsurface pigmentation, vascular damage, and collagen breakdown invisible to the naked eye. Practices using imaging in consultations report significantly higher package close rates and stronger patient trust — patients see their own skin data and self-justify the spend.
Affects: Consultation conversion
Medium Relevance ↗
Industry
2 weeks ago
NAD+ IV Therapy Up 44% YoY as Longevity Medicine Moves Mainstream
Wellness Business Journal · AMSPA 2025 Data
The longevity wellness market is driving significant crossover into med spas, with NAD+ drips, peptide protocols, and hormone optimization becoming core revenue drivers. Average NAD+ session ticket runs $250–$400 with high return visit frequency. Practices adding a dedicated wellness menu are seeing 20%+ revenue lift.
Affects: IV therapy, wellness menu
Medium Relevance ↗
Regulatory
⚠ Action Required
2 weeks ago
Medical Board Updates RN Supervision Requirements for Aesthetic Injections
State Medical Board · Nursing Board Joint Guidance
Updated guidance clarifies physician supervision requirements for RNs performing aesthetic injections in medical spa settings. Practices operating under collaborative practice agreements should confirm their protocols are compliant with the revised framework. Non-compliance risk window closes end of quarter.
Affects: Compliance, operations
Review Before Q3 ⚠
